Immunostimulatory biodegradable implants containing the adjuvant Quil-A—Part I: Physicochemical characterisation

By Myschik Julia   Eberhardt Friederike   Rades Thomas   Hook Sarah  

Journal of Drug Targeting, Vol. 16, Iss. 3, 2008-04 ,pp. : 213-223

Informa Healthcare

Access to resources Recommend Favorite

Safety Evaluation of Monophosphoryl Lipid A (MPL): An Immunostimulatory Adjuvant

By Baldrick P.   Richardson D.   Elliott G.   Wheeler A.W.  

Regulatory Toxicology and Pharmacology, Vol. 35, Iss. 3, 2002-06 ,pp. : 398-413

Academic Press

Access to resources Recommend Favorite

Immunogenicity of Liposomes Containing Lipid Core Peptides and the Adjuvant Quil A

By White Karen   Rades Thomas   Kearns Philip   Toth Istvan   Hook Sarah  

Pharmaceutical Research, Vol. 23, Iss. 7, 2006-07 ,pp. : 1473-1481

Springer Publishing Company

Access to resources Recommend Favorite

In vivo-in vitro study of biodegradable and osteointegrable gentamicin bone implants

By Sanchez E.   Baro M.   Soriano I.   Perera A.   Evora C.  

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 52, Iss. 2, 2001-09 ,pp. : 151-158

Elsevier

Access to resources Recommend Favorite

Development and evaluation of a pulsatile drug delivery system using novel polymer. Part II: In vivo radio imaging study

By Tekade Avinash R.   Gattani Surendra G.  

Pharmaceutical Development and Technology, Vol. 15, Iss. 6, 2010-12 ,pp. : 666-668

Informa Healthcare

Access to resources Recommend Favorite